ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,424.20
0.05%
Dow Jones
39,806.77
-0.49%
Gold vs US Dollar
2,412.99
-0.56%
Brent Oil
83.095
-0.52%
Bitcoin
71,082.25
-0.51%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Rigel Pharmaceuticals Inc (RIGL) Share Price

RIGL Rigel Pharmaceuticals Inc

0.968
0.0176 (1.85%)
21 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Rigel Pharmaceuticals Inc NASDAQ:RIGL NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.0176 1.85 0.968 0.9401 1.01 0.979 0.9402 0.97 417,866 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 116.88M -25.09M -0.1431 -6.64 166.61M
 Type  Size  Price  Time  Units 
 9 1 0.9799 23:43:49 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore RIGL News
07/05/202421:16EDGAR2Form 8-K - Current report
07/05/202421:01PRNUSRigel Reports First Quarter 2024 Financial Results and Provides Business Update
30/04/202413:05PRNUSRigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
10/04/202421:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04/04/202413:05PRNUSRigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
12/03/202412:05PRNUSRigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
05/03/202421:10EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for RIGL

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Rigel Pharmaceuticals Inc Articles